Article Text

Download PDFPDF
Novel mutation in the choroideremia gene and multi-Mendelian phenotypes in Spanish families
  1. Marta de Castro-Miró1,2,3,
  2. Raul Tonda4,5,
  3. Gemma Marfany1,2,3,
  4. Ricardo P Casaroli-Marano6,
  5. Roser Gonzàlez-Duarte1,2,3
  1. 1 Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
  2. 2 Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain
  3. 3 Institut de Biomedicina (IBUB), Universitat de Barcelona, Barcelona, Spain
  4. 4 CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
  5. 5 Universitat Pompeu Fabra (UPF), Barcelona, Spain
  6. 6 Department of Surgery, School of Medicine and Hospital Clínic de Barcelona (IDIBAPS), University of Barcelona, Barcelona, Spain
  1. Correspondence to Dr Roser Gonzàlez-Duarte, Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Barcelona 08028, Spain; rgonzalez{at}ub.edu

Footnotes

  • RPC-M and RG-D contributed equally.

  • Contributors Conceptualisation: MdC-M, RT, RPC-M and RG-D. Data curation, investigation, methodology: MdC-M, RT and RPC-M. Formal analysis: MdC-M, RPC-M and RG-D. Funding acquisition and project administration: RG-D. Resources: RPC-M and RG-D. Software: MdC-M and RT. Supervision: GM and RG-D. Validation and visualisation: MdC-M and RPC-M. Writing, original draft: GM and RG-D. Writing, review and editing: all authors.

  • Funding The study was supported by the 2013 CNAG Call '300 EXOMES TO ELUCIDATE RARE DISEASES'. This activity was sponsored by grants SAF2013-49069-C2-R-1 (Ministerio de Economía y Competitividad/FEDER), 2014SGR-0932 (Generalitat de Catalunya), La Marató TV3 (Project Marató 201417-30-31-32) to GM and RGD. RT is funded by PT13/0001/0044 (ISCIII Ministerio de Economía y Competitividad).

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval All the research procedures were approved by the Bioethics Committee of the Universitat de Barcelona (Barcelona, Spain).

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • RPC-M and RG-D contributed equally.

  • Contributors Conceptualisation: MdC-M, RT, RPC-M and RG-D. Data curation, investigation, methodology: MdC-M, RT and RPC-M. Formal analysis: MdC-M, RPC-M and RG-D. Funding acquisition and project administration: RG-D. Resources: RPC-M and RG-D. Software: MdC-M and RT. Supervision: GM and RG-D. Validation and visualisation: MdC-M and RPC-M. Writing, original draft: GM and RG-D. Writing, review and editing: all authors.

  • Funding The study was supported by the 2013 CNAG Call '300 EXOMES TO ELUCIDATE RARE DISEASES'. This activity was sponsored by grants SAF2013-49069-C2-R-1 (Ministerio de Economía y Competitividad/FEDER), 2014SGR-0932 (Generalitat de Catalunya), La Marató TV3 (Project Marató 201417-30-31-32) to GM and RGD. RT is funded by PT13/0001/0044 (ISCIII Ministerio de Economía y Competitividad).

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval All the research procedures were approved by the Bioethics Committee of the Universitat de Barcelona (Barcelona, Spain).

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • At a glance
    Keith Barton Jost B Jonas James Chodosh